| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |